Vincent Andrews
Stock Analyst at Morgan Stanley
(3.84)
# 727
Out of 4,761 analysts
307
Total ratings
65.66%
Success rate
27.64%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Vincent Andrews
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ALB Albemarle | Maintains: Underweight | $73 → $68 | $81.19 | -16.25% | 12 | Feb 18, 2025 | |
| BG Bunge Global | Maintains: Equal-Weight | $90 → $74 | $73.17 | +1.13% | 12 | Feb 11, 2025 | |
| ADM Archer-Daniels-Midland Company | Maintains: Equal-Weight | $52 → $47 | $48.15 | -2.39% | 18 | Feb 11, 2025 | |
| FMC FMC Corporation | Maintains: Equal-Weight | $70 → $46 | $38.26 | +20.23% | 15 | Feb 5, 2025 | |
| LYB LyondellBasell Industries | Maintains: Overweight | $90 → $85 | $77.11 | +10.24% | 10 | Feb 4, 2025 | |
| DOW Dow Inc. | Maintains: Equal-Weight | $46 → $43 | $39.52 | +8.81% | 16 | Jan 31, 2025 | |
| SHW The Sherwin-Williams Company | Maintains: Overweight | $450 → $405 | $344.78 | +17.47% | 23 | Jan 28, 2025 | |
| ECL Ecolab | Upgrades: Overweight | $263 → $280 | $264.52 | +5.85% | 15 | Jan 28, 2025 | |
| TROX Tronox Holdings | Maintains: Equal-Weight | $16 → $12 | $7.93 | +51.32% | 11 | Jan 13, 2025 | |
| CC The Chemours Company | Maintains: Equal-Weight | $25 → $22 | $16.87 | +30.45% | 15 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $100 → $80 | $52.47 | +52.47% | 16 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $88 → $94 | $81.73 | +15.01% | 9 | Oct 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $65 | $62.87 | +3.39% | 11 | Sep 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $240 → $280 | $310.03 | -9.69% | 13 | Jun 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $70 → $85 | $78.10 | +8.83% | 17 | Aug 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Equal-Weight | $32 | $35.93 | -10.94% | 9 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $420 | $458.09 | -8.31% | 9 | Aug 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $115 | $98.95 | +16.22% | 14 | Aug 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $143 → $155 | $114.75 | +35.08% | 16 | Jul 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $100 → $91 | $52.64 | +72.87% | 11 | Jan 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $60 → $55 | $25.82 | +113.05% | 13 | Jan 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $12 → $8.5 | $6.18 | +37.65% | 8 | Jan 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $45 → $57 | $43.62 | +30.69% | 4 | May 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Overweight | $160 | $79.92 | +100.20% | 1 | Apr 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | n/a | $121.20 | - | 9 | Dec 14, 2020 |
Albemarle
Feb 18, 2025
Maintains: Underweight
Price Target: $73 → $68
Current: $81.19
Upside: -16.25%
Bunge Global
Feb 11, 2025
Maintains: Equal-Weight
Price Target: $90 → $74
Current: $73.17
Upside: +1.13%
Archer-Daniels-Midland Company
Feb 11, 2025
Maintains: Equal-Weight
Price Target: $52 → $47
Current: $48.15
Upside: -2.39%
FMC Corporation
Feb 5, 2025
Maintains: Equal-Weight
Price Target: $70 → $46
Current: $38.26
Upside: +20.23%
LyondellBasell Industries
Feb 4, 2025
Maintains: Overweight
Price Target: $90 → $85
Current: $77.11
Upside: +10.24%
Dow Inc.
Jan 31, 2025
Maintains: Equal-Weight
Price Target: $46 → $43
Current: $39.52
Upside: +8.81%
The Sherwin-Williams Company
Jan 28, 2025
Maintains: Overweight
Price Target: $450 → $405
Current: $344.78
Upside: +17.47%
Ecolab
Jan 28, 2025
Upgrades: Overweight
Price Target: $263 → $280
Current: $264.52
Upside: +5.85%
Tronox Holdings
Jan 13, 2025
Maintains: Equal-Weight
Price Target: $16 → $12
Current: $7.93
Upside: +51.32%
The Chemours Company
Jan 13, 2025
Maintains: Equal-Weight
Price Target: $25 → $22
Current: $16.87
Upside: +30.45%
Jan 13, 2025
Maintains: Equal-Weight
Price Target: $100 → $80
Current: $52.47
Upside: +52.47%
Oct 21, 2024
Maintains: Equal-Weight
Price Target: $88 → $94
Current: $81.73
Upside: +15.01%
Sep 24, 2024
Maintains: Overweight
Price Target: $65
Current: $62.87
Upside: +3.39%
Jun 5, 2024
Maintains: Equal-Weight
Price Target: $240 → $280
Current: $310.03
Upside: -9.69%
Aug 7, 2023
Maintains: Equal-Weight
Price Target: $70 → $85
Current: $78.10
Upside: +8.83%
Aug 4, 2023
Reiterates: Equal-Weight
Price Target: $32
Current: $35.93
Upside: -10.94%
Aug 1, 2023
Reiterates: Overweight
Price Target: $420
Current: $458.09
Upside: -8.31%
Aug 1, 2023
Reiterates: Overweight
Price Target: $115
Current: $98.95
Upside: +16.22%
Jul 24, 2023
Maintains: Equal-Weight
Price Target: $143 → $155
Current: $114.75
Upside: +35.08%
Jan 11, 2023
Maintains: Equal-Weight
Price Target: $100 → $91
Current: $52.64
Upside: +72.87%
Jan 11, 2023
Maintains: Equal-Weight
Price Target: $60 → $55
Current: $25.82
Upside: +113.05%
Jan 11, 2023
Maintains: Equal-Weight
Price Target: $12 → $8.5
Current: $6.18
Upside: +37.65%
May 12, 2021
Maintains: Equal-Weight
Price Target: $45 → $57
Current: $43.62
Upside: +30.69%
Apr 12, 2021
Reinstates: Overweight
Price Target: $160
Current: $79.92
Upside: +100.20%
Dec 14, 2020
Downgrades: Equal-Weight
Price Target: n/a
Current: $121.20
Upside: -